Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2335]

ASCO GU: Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer

ASCO GU: Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer

ASCO GU: Approximately one in five adult cancer clinical trials fails to complete

ASCO GU: Approximately one in five adult cancer clinical trials fails to complete

ASCO GI: Ras status predicts response to second-line treatment with panitumumab for metastatic colorectal cancer

ASCO GI: Ras status predicts response to second-line treatment with panitumumab for metastatic colorectal cancer

ASCO GI: Pre-operative oral capecitabine chemotherapy is equivalent to infusional 5-FU for rectal cancer

ASCO GI: Pre-operative oral capecitabine chemotherapy is equivalent to infusional 5-FU for rectal cancer

ASCO GI: Adding the targeted therapy ramucirumab to standard second-line chemotherapy improves survival, quality of life for patients with metastatic gastric cancer

ASCO GI: Adding the targeted therapy ramucirumab to standard second-line chemotherapy improves survival, quality...

European Commission approves update of cetuximab metastatic colorectal cancer labeling to patients with RAS wild-type tumours

European Commission approves update of cetuximab metastatic colorectal cancer labeling to patients with RAS wild...

Semantic Web Applications and Tools for Life Sciences (SWAT4LS Workshop in Edinburgh 2013)

Semantic Web Applications and Tools for Life Sciences (SWAT4LS Workshop in Edinburgh 2013)

Computer-controlled table could direct radiotherapy to tumours while sparing vital organs

Computer-controlled table could direct radiotherapy to tumours while sparing vital organs

UK cancer death rates drop by 20 per cent over 20 years

UK cancer death rates drop by 20 per cent over 20 years

Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed

Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed

More from ecancer